Ivan Bièche

发表

Newly characterised ex vivo colospheres as a three-dimensional colon cancer cell model of tumour aggressiveness

S. Richon, L. weiswald, G. Massonnet, 2009, British Journal of Cancer.

Donor/recipient origin of lung cancer after lung transplantation by DNA short tandem repeat analysis

Romane Beaurepere, J. de Wolf, M. Glorion, 2023, Frontiers in oncology.

Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays.

O. Cussenot, I. Bièche, M. Vidaud, 2001, Cancer research.

Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP.

P. Pineau, S. Vacher, I. Bièche, 2006, Gene.

Overexpression of the stathmin gene in a subset of human breast cancer.

I. Bièche, V. Bécette, R. Lidereau, 1998, British Journal of Cancer.

A gene dosage effect is responsible for high overexpression of the MUC1 gene observed in human breast tumors.

I. Bièche, R. Lidereau, Ivan Bièche, 1997, Cancer genetics and cytogenetics.

Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer

I. Bièche, R. Lidereau, R. Callahan, 1992, The Lancet.

Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer

E. Zabarovsky, I. Bièche, M. Broggini, 2008, Oncogene.

Overexpression of BRCA2 gene in sporadic breast tumours

I. Bièche, R. Lidereau, C. Noguès, 1999, Oncogene.

Analyses of MYC, ERBB2, and CCND1 genes in benign and malignant thyroid follicular cell tumors by real-time polymerase chain reaction.

I. Bièche, M. Vidaud, R. Lidereau, 2001, Thyroid : official journal of the American Thyroid Association.

Hedgehog pathway activation in human transitional cell carcinoma of the bladder

S. Vacher, I. Bièche, R. Lidereau, 2012, British Journal of Cancer.

Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays

I. Bièche, M. Vidaud, R. Lidereau, 2002, British Journal of Cancer.

Two distinct amplified regions at 17q11-q21 involved in human primary breast cancer.

I. Bièche, R. Lidereau, C. Tomasetto, 1996, Cancer research.

Quantitative gene expression in Budd-Chiari syndrome: a molecular approach to the pathogenesis of the disease

M. Vidaud, I. Laurendeau, D. Dargère, 2005, Gut.

Increased level of exon 12 alternatively spliced BRCA2 transcripts in tumor breast tissue compared with normal tissue.

I. Bièche, R. Lidereau, Ivan Bièche, 1999, Cancer research.

The Activation of the WNT Signaling Pathway Is a Hallmark in Neurofibromatosis Type 1 Tumorigenesis

E. Pasmant, I. Laurendeau, B. Parfait, 2013, Clinical Cancer Research.

NF-kappa B genes have a major role in Inflammatory Breast Cancer

M. Espié, S. Vacher, I. Bièche, 2008, BMC Cancer.

Two distinct regions involved in 1p deletion in human primary breast cancer.

I. Bièche, R. Lidereau, C. Cropp, 1993, Cancer research.

A tumor suppressor gene on chromosome 1p32-pter controls the amplification of MYC family genes in breast cancer.

I. Bièche, R. Lidereau, M. Champème, 1994, Cancer research.

ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels

S. Vacher, I. Bièche, R. Lidereau, 2015, British Journal of Cancer.

Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay.

V. Paradis, I. Bièche, M. Vidaud, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.